InvestorsHub Logo
Followers 58
Posts 10089
Boards Moderated 1
Alias Born 09/21/2016

Re: XenaLives post# 120610

Monday, 09/18/2017 7:57:09 AM

Monday, September 18, 2017 7:57:09 AM

Post# of 459914
Gotta like this:

These methods have been used with some of the newer immunological therapies. It may also be used in other drugs targeted against specific molecular defects. Seamless designs are particularly advantageous for drugs that work in a variety of diseases, allowing rapid evaluation of the drug and potential approval under our accelerated approval pathway. These new approaches are also highly consistent with the goals of the 21st Century Cures Act and the recently passed FDA Reauthorization Act.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News